Utah Medical Products, Inc.
UTMD
$58.72
$0.390.67%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.80% | -8.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.80% | -8.29% | |||
| Cost of Revenue | 1.35% | -9.34% | |||
| Gross Profit | -7.21% | -7.58% | |||
| SG&A Expenses | -2.65% | 3.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.23% | -5.65% | |||
| Operating Income | -7.78% | -12.11% | |||
| Income Before Tax | -0.76% | -12.23% | |||
| Income Tax Expenses | -18.73% | -9.98% | |||
| Earnings from Continuing Operations | 3.19% | -12.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.19% | -12.71% | |||
| EBIT | -7.78% | -12.11% | |||
| EBITDA | -5.68% | -10.35% | |||
| EPS Basic | 4.78% | -10.57% | |||
| Normalized Basic EPS | -3.78% | -10.54% | |||
| EPS Diluted | 4.32% | -10.29% | |||
| Normalized Diluted EPS | -3.78% | -10.53% | |||
| Average Basic Shares Outstanding | -1.52% | -2.39% | |||
| Average Diluted Shares Outstanding | -1.52% | -2.39% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.06% | 0.14% | |||
